ADHD Treatment Powered by Brain Training

LumosityRx is an FDA-cleared, prescription therapeutic app that improves attention in adults with ADHD.

Improved Attention and Quality of Life

Results from our pivotal study with over 500 adults with ADHD

Improved Attention

Average attention functioning improved by 1.1 points — measured using the TOVA®, a validated measure of attention.

Superior Clinical Improvement

In a global measure of clinical improvement (CGI-I), assessed by blinded clinicians, there was superior clinical benefit for LumosityRx users compared to a control group.

Improved Quality of Life

Participants demonstrated a clinically meaningful mean improvement in their quality of life — 8.7 points on the Adult ADHD Quality of Life Questionnaire [AAQoL].

Designed to Improve Your Attention

LumosityRx delivers 13 cognitive exercises that train attention, working memory, and cognitive control. Built on neuroscience, optimized for clinical use.

Engaging Game-Based Experience

MOTIVATING AND IMMERSIVE

Personalized Daily Regimen

~15 MINUTES/DAY, ADAPTS TO PROGRESS

In-App Feedback

TRACK IMPROVEMENTS AND HABITS

Frequently Asked Questions

Everything you need to know about LumosityRx

A prescription digital therapeutic (PDT) is a software-based intervention that delivers medical treatment directly to patients. Unlike general health apps, PDTs are clinically validated, FDA-cleared, and require a prescription from a healthcare provider.

In a clinical study, LumosityRx users reported no serious device-related adverse events. Only 2 users (0.7%) reports of frustration that resolved with conclusion of gameplay. Always consult your healthcare provider about personalized medical advice.

LumosityRx is indicated for certain adults who have been diagnosed with ADHD. It is available by prescription from a licensed healthcare provider.

LumosityRx is built on the same science-backed technology behind Lumosity but is specifically optimized, validated, and cleared for clinical use in adults with ADHD. While Lumosity is designed for general brain training, it is not intended to diagnose, treat, cure, or prevent any medical condition.

Everyone's needs are different — the best next step is to talk to your doctor about how LumosityRx might fit into your overall treatment plan.

Be the First to Access LumosityRx

We'll send you updates on our progress, including when LumosityRx is available.

Indications for Use

LumosityRx was cleared by the FDA under the name "Prismira."

Indications for Use: Prismira is a digital therapeutic indicated to improve attention function in adults ages 22-55 years old with primarily inattentive or combined-type Attention Deficit and Hyperactivity Disorder (ADHD). Patients who engage with Prismira demonstrate improvements in a digitally assessed measure of sustained and selective attention, Test of Variables of Attention (TOVA), and may not display benefits in typical behavioral symptoms, such as hyperactivity. Prismira should be considered for use as part of a therapeutic program that may include clinician directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.

Limitations: Prismira may not be appropriate for users with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device. Always consult with your healthcare provider before starting any new treatment. This information does not replace professional medical advice, diagnosis, or treatment.